Vivani Medical Inc. (NASDAQ:VANI) — Market Cap & Net Worth
Market Cap & Net Worth: Vivani Medical Inc. (VANI)
Vivani Medical Inc. (NASDAQ:VANI) has a market capitalization of $109.15 Million ($109.15 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18960 globally and #4384 in its home market, demonstrating a -7.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vivani Medical Inc.'s stock price $1.21 by its total outstanding shares 90203356 (90.20 Million). Also see Vivani Medical Inc. total assets for a full breakdown of the balance sheet.
Vivani Medical Inc. Market Cap History: 2015 to 2026
Vivani Medical Inc.'s market capitalization history from 2015 to 2026. Data shows change from $12.75 Billion to $109.15 Million (-36.66% CAGR). Also see Vivani Medical Inc. (VANI) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Vivani Medical Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #539 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1836 of 3165 |
Weight: Vivani Medical Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vivani Medical Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vivani Medical Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Vivani Medical Inc. share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1696516.96x
Vivani Medical Inc.'s market cap is 1696516.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.26 Billion | $3.98 Million | -$33.18 Million | 1070.22x | N/A |
| 2017 | $4.13 Billion | $7.96 Million | -$28.52 Million | 519.20x | N/A |
| 2018 | $1.92 Billion | $6.90 Million | -$35.09 Million | 278.14x | N/A |
| 2019 | $1.61 Billion | $3.38 Million | -$33.59 Million | 475.39x | N/A |
| 2020 | $506.04 Million | $1.00K | -$9.28 Million | 506040.83x | N/A |
| 2021 | $441.09 Million | $260.00 | -$12.77 Million | 1696516.96x | N/A |
Competitor Companies of VANI by Market Capitalization
Companies near Vivani Medical Inc. in the global market cap rankings as of September 18, 2026. Review VANI goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Vivani Medical Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Vivani Medical Inc. Historical Marketcap From 2015 to 2026
Between 2015 and today, Vivani Medical Inc.'s market cap moved from $12.75 Billion to $ 109.15 Million, with a yearly change of -36.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $109.15 Million | -1.63% |
| 2025 | $110.95 Million | +6.03% |
| 2024 | $104.64 Million | +13.73% |
| 2023 | $92.01 Million | +20.00% |
| 2022 | $76.67 Million | -82.62% |
| 2021 | $441.09 Million | -12.83% |
| 2020 | $506.04 Million | -68.50% |
| 2019 | $1.61 Billion | -16.25% |
| 2018 | $1.92 Billion | -53.61% |
| 2017 | $4.13 Billion | -3.05% |
| 2016 | $4.26 Billion | -66.55% |
| 2015 | $12.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Vivani Medical Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $109.15 Million USD |
| MoneyControl | $109.15 Million USD |
| MarketWatch | $109.15 Million USD |
| marketcap.company | $109.15 Million USD |
| Reuters | $109.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more